The Medicines Optimisation team would like to invite you to an education evening on the management of COPD and asthma patients with inhaled respiratory drugs medication.
Following a recent survey carried out by the Medicines Optimisation team there is growing recognition that there are now a considerable number of inhaled respiratory products and devices available which make it challenging for healthcare professionals to ensure that the appropriate treatment and device is provided to patients.
We therefore invite you to our respiratory update which will cover the following topics:
Dr Mitesh Patel, Consultant Respiratory Physician:
- Treatment of COPD and use of the GOLD guidance
- When and how to step down ICS doses in COPD and Asthma patient
NEW Devon CCG Medicines Optimisation Team:
- Newer inhaler devices, resources and formulary updates
This event will be delivered by the Medicines Optimisation team although funded by a limited number of pharmaceutical companies including; Pfizer, GSK and Teva UK Limited who currently have inhaled respiratory products listed on the local Joint Formulary. Please note that these companies will have no input into the design or content of the event but will be in attendance at the event and will provide sponsorship via the provision of exhibition stands.
If you have any queries please do not hesitate to contact us.